Brought to you by 
Cygnus acquires rights to glucose monitoring tech. from PWLP
13 Jul 1999
Executive Summary
Cygnus Therapeutic Systems (drug delivery and non-invasive monitoring products) has acquired all rights to a non-invasive glucose monitoring technology it developed through an R&D collaboration with PaineWebber R&D Partners II LP (PWLP).
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Financing
- Other
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cygnus acquires rights to glucose monitoring tech. from PWLP
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice